Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 382 followers

Latest posts

Last updated about 5 hours ago

ESMO: Merck spotlights details of Keytruda's landmark win in ovarian cancer

about 5 hours ago

Merck offered a closer look at Keytruda's overall survival benefits in a...

ESMO: Keytruda, Padcev reduce risk of death by 50% in another massive showing in bladder cancer

about 5 hours ago

The standing ovation for Keytruda and Padcev in metastatic bladder cancer at...

ESMO: AZ, Daiichi unleash Enhertu's 2-fisted power, aiming to reshape early breast cancer landscape

about 5 hours ago

AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout...

Amgen, AZ's Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent

about 22 hours ago

The FDA has endorsed Amgen and AstraZeneca’s Tezspire as an add-on maintenance...

Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics

1 day ago

Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics

Merck KGaA’s EMD Serono strikes MFN deal in Trump's fertility treatment pricing push

1 day ago

Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer...

Sanofi gets one thumbs up, one thumbs down from Europe's CHMP

1 day ago

Europe’s Committee for Medicinal Products for Human Use (CHMP) has given a...

Fierce Pharma Asia—High-dollar licensing deals, Takeda's AI drug design pact and the finale of Novo vs. KBP

1 day ago

Dianthus and Boehringer Ingelheim headlined the latest round of licensing deals featuring...

Big pharma bets big on MASH with a new combo playbook

1 day ago

After Rezdiffra’s approval and Wegovy’s label expansion, the race is on in...

FDA names 9 first recipients of 1- to 2-month priority review vouchers

1 day ago

The FDA has handed out the first nine national priority vouchers, positioning...

ESMO: Results for AZ's Imfinzi in early bladder cancer type suggest it measures up to Pfizer candidate

1 day ago

Results presented by AstraZeneca from its phase 3 trial of Imfinzi in...

Eli Lilly's Verzenio secures overall survival win, bolstering early breast cancer case

1 day ago

Eli Lilly hopes its latest overall survival win could increase the adoption...